000 | 01949 a2200517 4500 | ||
---|---|---|---|
005 | 20250513031911.0 | ||
264 | 0 | _c19951006 | |
008 | 199510s 0 0 eng d | ||
022 | _a0732-183X | ||
024 | 7 |
_a10.1200/JCO.1995.13.9.2230 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLilenbaum, R C | |
245 | 0 | 0 |
_aPhase I study of paclitaxel and topotecan in patients with advanced tumors: a cancer and leukemia group B study. _h[electronic resource] |
260 |
_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _cSep 1995 |
||
300 |
_a2230-7 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
650 | 0 | 4 |
_aCamptothecin _xadministration & dosage |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFilgrastim |
650 | 0 | 4 |
_aGranulocyte Colony-Stimulating Factor _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
650 | 0 | 4 |
_aNeutropenia _xchemically induced |
650 | 0 | 4 |
_aPaclitaxel _xadministration & dosage |
650 | 0 | 4 |
_aRecombinant Proteins _xtherapeutic use |
650 | 0 | 4 | _aRemission Induction |
650 | 0 | 4 |
_aThrombocytopenia _xchemically induced |
650 | 0 | 4 | _aTopotecan |
650 | 0 | 4 | _aUnited States |
700 | 1 | _aRatain, M J | |
700 | 1 | _aMiller, A A | |
700 | 1 | _aHargis, J B | |
700 | 1 | _aHollis, D R | |
700 | 1 | _aRosner, G L | |
700 | 1 | _aO'Brien, S M | |
700 | 1 | _aBrewster, L | |
700 | 1 | _aGreen, M R | |
700 | 1 | _aSchilsky, R L | |
773 | 0 |
_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 13 _gno. 9 _gp. 2230-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1200/JCO.1995.13.9.2230 _zAvailable from publisher's website |
999 |
_c7544677 _d7544677 |